期刊文献+

基层医院房颤患者使用华法林抗凝治疗体会 被引量:1

Experience of Warfarin anticoagulant therapy for atrial fibrillation patients in primary hospital
下载PDF
导出
摘要 目的探讨华法林在基层医院应用的并发症和随访率。方法将入选心内科住院并服用华法林的房颤患者42例作为观察组,纳入同期门诊房颤合并瓣膜病并行换瓣手术后服用华法林患者14例作为对照组,随访6个月,观察2组患者的随诊率、出血发生率、缺血性脑卒中发生率、病死率。结果 2组患者均无缺血性脑卒中发生,对照组按时随诊率100%,无并发症发生。观察组按时随诊率69.4%,发生出血并发症高达30.95%,其中脑出血死亡1例(2.4%);出血并发症全部发生在未按时随诊患者中,其中农村患者占84.60%。结论华法林预防缺血性脑卒中效果肯定,出血并发症主要出现在未按时随诊农村患者中,患者的依从性是华法林在基层医院应用的主要挑战。 Objective To investigate the complications and follow-up rate of warfarin application in primary hospital. Methods Twenty-four atrial fibrillation patients with warfarin administration in department of cardiology were enrolled as observation group. At the same period, fourteen atrial fibrillation patients with heart valve postoperation in clinic were enrolled as control group .The two group patients followed up for six months. The incidence of followed-up, ischemic, hemorrhagic stroke and mortality was observed for analysis. Results There were no ischemic stroke occurred in the two groups. The timely follow-up rate was 100% in control group,and there were no complications. The timely follow-up rate was 69.4% in observation group, and the hemorrhagic complications as high as 30.95%, in which there was one patient died of hemorrhagic stroke. All of the hemorrhagic complications took place in failing timely follow-up patients,in which the rual area patients accont for 84.60%.Conclusion Warfarin is effective in preventing ischemic stroke,The hemorrhagic complications mostly took place in rual area patients who failed timely follow-up,So the challenges of the application of warfarin in primary hospitals mainly come from the patients, compliance.
作者 龚福汉 肖小强 张学平 Gong Fuhan Xiao Xiaoqiang Zhang Xueping.(The People 's Hospital of Tongren City , Tongren, Guizhou 55430)
机构地区 铜仁市人民医院
出处 《基层医学论坛》 2016年第25期3472-3473,共2页 The Medical Forum
关键词 房颤 华法林 抗凝 基层医院 Atrial fibrillation Warfarin Anticoagulation Primary hospital
  • 相关文献

参考文献6

  • 1陈伟伟,高润霖,刘力生,朱曼璐,王文,王拥军,吴兆苏,李惠君,郑哲,蒋立新,胡盛寿.《中国心血管病报告2014》概要[J].中国循环杂志,2015,30(7):617-622. 被引量:796
  • 2黄从新,张澍,黄德嘉,曹克将,陈柯萍,陈明龙,董建增,华伟,黄鹤,江洪,李莉,刘少稳,刘旭,刘兴鹏,刘育,马长生,马坚,孟旭,商丽华,苏晞,唐其柱,王祖禄,吴立群,吴书林,夏云龙,杨杰孚,杨新春,杨延宗,杨艳敏,姚焰,郑哲.心房颤动:目前的认识和治疗建议-201[J].中国心脏起搏与心电生理杂志,2015,29(5):377-434. 被引量:197
  • 3CONNILLY S J.Atrial Fibrillation in 2010:Advances in treatment and management[J]. Nat Rev Cardiol,2011,8(2) :67-85.
  • 4JANUARY C T,WANN L S,ALPERT J S ,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Assiation Task Force on Practice Guidelines and the Heart Rhythm Society [J].J Am Coil Cardiol, 2014,64( 21 ) : 1-76.
  • 5胡益蓉,杜丽,王梅.基层医院心房纤颤患者华法林抗凝使用回顾性调查分析[J].实用心脑肺血管病杂志,2010,18(7):896-897. 被引量:6
  • 6马长生.用好房颤抗凝新伙伴[N].中国医药报,2015-4-22(006).

二级参考文献27

共引文献996

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部